Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States - Concepedia

Concepedia

Publication | Open Access

Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States

DOI Full Paper Access

17

Citations

36

References

2023

Year

Rahul Mudumba, Hui-Hsuan Chan, Yuanyuan Cheng, Chien-Chen Wang, Luís Correia, Jeromie Ballreich, Joseph Levy

Value in Health

Breast OncologyOncologyCost-effectiveness AnalysisBreast CancerCancer TreatmentUnited StatesMedicineRadiation Oncology

References

	Year	Citations

Page 1